Blinatumomab has been shown to improve outcomes in children with relapsed B-cell ALL, but the effects in children with newly diagnosed disease have been unclear. New research findings are ...

KU School of Medicine-Wichita Doctors Nathan Hall and Brian Pate helped to bring the treatment, “blinatumomab”, to Wichita in the fall of 2024. For patients with an average risk of relapse ...

Blinatumomab, which recently completed clinical trials and has won approval from the FDA, is a drug designed to treat acute lymphoblastic leukemia, one of the most common types of blood and bone ...

The National Institute for Health and Care Excellence (NICE) has recommended blinatumomab with chemotherapy for National Health Service (NHS) use in adults with aggressive leukaemia. The ...